US Patent 9850320 Heterodimeric antibodies to CD3 X CD20
Patent 9850320 was granted and assigned to Xencor on December, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+83 characters)
Article
Patent abstract
The present invention is directed to novel heterodimeric antibodies.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Gregory Moore0
John Desjarlais0
Matthew J. Bernett0
Rumana Rashid0
Seung Chu0
Sung-Hyung Lee0
Umesh Muchhal0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09850320 Heterodimeric antibodies to CD3 X CD20 US Patent 9850320 Heterodimeric antibodies to CD3 X CD20
Infobox
Patent Number
09850320
Patent Number
9850320
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09850320 Heterodimeric antibodies to CD3 X CD20
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09850320
Date of patent
December 26, 2017
Patent application number
15185958
Date Filed
June 17, 2016
Patent primary examiner
Find more entities like US Patent 9850320 Heterodimeric antibodies to CD3 X CD20
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.